GeoVax Labs, Inc. - GOVX - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

GeoVax Labs, Inc. - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
GOVX	Over the counter	2834	http://www.geovax.com/	0.52 -0.01
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for GeoVax Labs, Inc. GEOVAX LABS, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Financial Statements and E - May 15th, 2013 12:59 am GEOVAX LABS, INC. Financials - May 8th, 2013 11:04 am 2013 Will be a Banner Year for GeoVax - May 6th, 2013 7:00 am 2013 Will be a Banner Year for GeoVax - May 6th, 2013 5:00 am GeoVax Labs Reports 2013 First Quarter Financial Results and Provides Clinical Development Update - May 2nd, 2013 7:00 am GEOVAX LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition - May 2nd, 2013 1:02 am GEOVAX LABS, INC. Files SEC form 10-Q, Quarterly Report - May 1st, 2013 6:33 am GEOVAX LABS, INC. Files SEC form 10-K, Annual Report - Mar 18th, 2013 1:10 am GeoVax is On Track to Advance its HIV/AIDS Vaccine Programs in 2013 - Mar 13th, 2013 9:28 am GeoVax is On Track to Advance its HIV/AIDS Vaccine Programs in 2013 - Mar 13th, 2013 7:00 am GEOVAX LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition - Mar 12th, 2013 12:41 pm GeoVax Labs Reports 2012 Financial Results and Progress - Mar 11th, 2013 7:00 am GeoVax Labs Launches New Corporate Website - Jan 23rd, 2013 8:00 am GeoVax (GOVX): Initiation with Outperform - Jan 23rd, 2013 6:48 am GEOVAX LABS, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Financial Statements and E - Jan 17th, 2013 9:38 am GeoVax Labs Releases Update Letter to Shareholders - Jan 15th, 2013 9:13 am GeoVax Labs Releases Update Letter to Shareholders - Jan 15th, 2013 7:00 am GeoVax Announces Enrollment Completion for Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine - Jan 10th, 2013 10:46 am GeoVax Announces Enrollment Completion for Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine - Jan 10th, 2013 7:00 am GeoVax Announces Full Enrollment of Phase 1 Clinical Trial for 2nd Generation HIV/AIDS Vaccine - Dec 19th, 2012 1:58 pm View All Current Headlines >>